Not recruitingEUCTR 2012-003313-34

A Phase 3, Multicenter, Open-label, 12-month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults with Binge Eating disorders

This historical record does not confirm current site availability.

Historical research recordMultiple countries

The study in practice

Understand this study

What is this study about?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations: Germany · Italy and 2 more locations
Study phase: Phase 3

Get this study by email

What to know before participating

A point to clarify

This is historical registry information. What is the current study status and protocol?

Study clarity

Things to check before joining

Study start dateNot clearly listed

Recruitment status: Not recruiting
Enrollment listed in the registry: 530
Sponsor: Shire Development LLC
Sponsor type: Other organization
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 3
Locations: Germany, Italy, Spain, ...
Age range: Not clearly listed
Official registry ID: EUCTR 2012-003313-34
Official title: Show the full official title
A Phase 3, Multicenter, Open-label, 12-month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults with Binge Eating Disorder

Recruitment & locations

Not recruiting

Germany · Italy · Spain

1 more locations

Sweden

Registry details

Historical country statuses

Germany — Completed
Spain — Completed
Italy — Prematurely Ended
Sweden — Completed

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Shire Development LLC.

Is this study still recruiting?

The historical registry lists this study as not recruiting.

Want to explore more studies?

Explore studies